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Introduction
Embryonic stem (ES) cells have pluripotent capacity for unlim-
ited growth and self-renewal and the ability to differentiate into 
mature cells, including vascular cell lineages. Recent studies have 
revealed the effects of ES cell–derived endothelial cells (ECs) on 
the formation of new vessels and improvements in cardiac func-
tion, implicating the potential of these cells to be used for progen-
itor cell–associated applications (Pittenger and Martin, 2004). 
Differentiation of ES cells toward the endothelial lineage is an 
important step in vasculogenesis, in which signals initiated by 
vascular endothelial growth factor (VEGF), FGF, and other cyto-
kines have been implicated. Most of our knowledge concerning 
endothelial differentiation from stem cells is derived from studies 
using growth factors and hypoxia environments, but less is known 
about the effect of mechanical forces on endothelial differentiation 
(Illi et al., 2005; Wang et al., 2005; Yamamoto et al., 2005).
ECs are critical cellular components of blood vessels, 
functioning as selectively permeable barriers between blood and 
tissues. The denudation or dysfunction of the intact endothelial 
monolayer causes lipid accumulation, monocyte adhension, and 
infl  ammatory reactions that initiate atherosclerotic lesion devel-
opment (Ross, 1999; Xu, 2006). Recently, accumulating evi-
dences indicate that endothelial progenitor cells (EPCs), possibly 
derived from adult stem cells, play an important role in endothe-
lial repair (Werner et al., 2002, 2003; Walter et al., 2002; Sata, 
2003; Xu et al., 2003; Rossig et al., 2005). During this process, 
incorporated EPCs are exposed to shear stress, which is a me-
chanical force generated by blood fl  ow. Several studies have 
shown that EPCs can differentiate into endothelial phenotypes 
when shear stress is applied (Yamamoto et al., 2003; Illi et al., 
2005; Wang et al., 2005; Yamamoto et al., 2005). However, the 
underlying mechanism remains to be elucidated.
The homeostasis between histone acetyltransferases and 
histone deacetylases (HDACs) regulates the structure and func-
tion of chromatin and some transcription factors, leading to gene 
transcription regulation. The HDAC family consists of 18 mem-
bers, which are categorized into three classes (Gray and Ekstrom, 
2001). HDAC3 belongs to class I HDACs, which contains four 
members, HDAC1, 2, 3, and 8, and is sensitive to trichostatin A 
(TSA). HDAC8 is reported to link with smooth muscle 
cell function (Waltregny et al., 2005). As HDAC1–3 are found 
expressed in most cell types in vitro, their role in cell differentiation 
is neglected. The aim of the present study was to investigate how 
laminar shear-initiated signal pathways were involved in stem 
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eendothelialization involves endothelial progenitor 
cell (EPC) homing, proliferation, and differentiation, 
which may be inﬂ  uenced by ﬂ  uid shear stress and 
local ﬂ  ow pattern. This study aims to elucidate the role of 
laminar ﬂ  ow on embryonic stem (ES) cell differentiation 
and the underlying mechanism. We demonstrated that 
laminar ﬂ   ow enhanced ES cell–derived progenitor cell 
proliferation and differentiation into endothelial cells (ECs). 
Laminar ﬂ  ow stabilized and activated histone deacetylase 
3 (HDAC3) through the Flk-1–PI3K–Akt pathway, which 
in turn deacetylated p53, leading to p21 activation. 
A similar signal pathway was detected in   vascular endo-
thelial growth factor–induced EC differentiation. HDAC3 
and p21 were detected in blood vessels during embryo-
genesis. Local transfer of ES cell–derived EPC incor-
porated into injured femoral artery and reduced 
neointima formation in a mouse model. These data sug-
gest that shear stress is a key regulator for stem cell dif-
ferentiation into EC, especially in EPC differentiation, 
which can be used for vascular repair, and that the 
Flk-1–PI3K–Akt–HDAC3–p53–p21 pathway is crucial in 
such a process.
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cell differentiation into ECs. We demonstrated that shear 
stress activated HDAC3 through the VEGF receptor 2 (Flk-1)–
PI3K–Akt signal pathway, and that HDAC3-mediated p53 
deacetylation and p21 activation was crucial for shear stress and 
VEGF-induced EC differentiation.
Results
Laminar ﬂ  ow promoted ES cell proliferation 
and differentiation
ES- or stem cell antigen-1–positive (Sca1
+) cells (vascular 
  progenitors) were cultured on collagen IV–coated plates in the 
absence of LIF, and then subjected to 12 dyne/cm
2 laminar shear 
stress. As shown in Fig. 1 A, laminar fl  ow increased the prolifer-
ation by  70% for both cells, as compared with static control. 
RT-PCR analysis revealed that withdrawal of LIF and culture 
on collagen IV–coated slides for 4 d increased mRNA expres-
sion of PECAM-1 (CD31), prominin 1 (CD133), VE-cadherin 
(CD144), VEGF receptor 1 (Flt-1), and VEGF receptor 2 (Flk-1) 
in both ES and Sca1
+ progenitor cells, which was further 
  enhanced by shear stress (unpublished data). Data shown in Fig. 
1 B indicate the increase of Flk-1 and endothelial nitric oxide 
synthase (eNOS) proteins by shear in ES cells. FACS analysis 
revealed that CD31
+ or CD133
+ cells increased slightly, whereas 
VCAM-1–positive (CD106
+) cells increased signifi  cantly, in 
response to shear stress (Fig. 1 C). These results suggest that 
laminar fl  ow increases the ES cell differentiation toward ECs.
To further explore whether the shear stress–induced, ES 
cell–derived ECs were functional, in vitro tube formation and 
in vivo neovascularization assays were performed. As shown in 
Fig. 1 D, sheared ES cells formed a tubelike structure on Matrigel, 
and no such structure was observed in the static control. After 
subcutaneous injection of cells mixed with Matrigel, the sheared 
cells formed capillary-like structures in all inoculations (6/6) at 
1 and 2 wk (Fig. 1 E, shear), whereas only 1/6 of the cells from 
static group formed capillary-like structures at 2 wk, but 3/6 at 
1 wk and 1/6 at 2 wk formed tumorlike structures (Fig. 1 E, 
static). To distinguish the exogenous ES cells from host cells, the 
ES cells were infected with the Ad-LacZ virus 12 h before  injection. 
The contribution of shear-induced ECs to the formation of new 
blood vessels was shown in Fig. 1 E from X-gal staining.
The impact of p53 and p21 
in ES cell differentiation
Because the p53–p21 pathway was reported in shear-induced cell 
cycle arrest in mature ECs (Akimoto et al., 2000; Lin et al., 2000; 
Figure 1.  Laminar ﬂ   ow resulted in ES cell–derived 
  progenitor cell proliferation and differentiation into ECs. 
(A) Shear-increased ES and Sca1
+ cell proliferation. 
(B) Shear-increased Flk-1 and eNOS protein levels in ES 
cells. ES, routinely cultured ES cell; ST, static; SH, shear. 
(C) FACS analysis for EC marker expression, including 
CD31, CD133, and CD106, in response to shear stress 
for 24 h. *, P < 0.05. (D) In vitro tube-formation assay 
with static and sheared-ES cells on Matrigel. (E) Hematox-
ylin and eosin (HE) and X-gal staining for sections from 
in vivo angiogenesis assay at day 14. The data are repre-
sentatives or means ± the SD of three independent experi-
ments. Bars, 100 μm.HDAC3 IN ENDOTHELIAL CELL DIFFERENTIATION • ZENG ET AL. 1061
Mattiussi et al., 2004), we wondered whether such a pathway 
was involved in shear-induced EC differentiation.  When laminar 
fl  ow was applied, the p53 and p21 proteins increased gradually 
as shear proceeded (Fig. 2 A). Double immunostaining showed 
a colocalization of p53 or p21 with EC markers, e.g., CD106 
(Fig. 2 B) and CD144 (not depicted). Overexpression of p53 
  increased CD144- and eNOS-Luc reporter gene expression, but 
slightly decreased Flk-1–Luc reporter gene expression in ES 
cells, whereas overexpression of p21 increased expression of all 
three reporter genes (Fig. 2 C).
To further confi  rm the impact of p53 and p21 in EC dif-
ferentiation, we overexpressed p53 in ES cells via adenoviral 
gene transfer. FACS analysis showed that overexpression of 
p53 increased CD31
+, CD106
+, and CD144
+ cell numbers, but 
caused no change in CD133
+ cells (Fig. 2 D). Western blot 
analysis indicated that p53 overexpression led to the increase of 
CD31, CD144, eNOS, and p21 proteins in a dose-dependent 
manner (unpublished data). When cells were infected with ade-
novirus carrying p53 and injected into mice with Matrigel, 
all inoculates (6/6) showed vascular structures, and only 1/6 
of controls displayed such a structure. Immunohistological 
staining revealed that all vascular structures were positive for 
p53, p21, and CD144 (Fig. 2 E). These results indicate that p53 
up-regulation and the concomitant p21 activation can promote 
EC differentiation in vitro and in vivo.
To explore whether p53 and p21 were essential for shear-
induced EC differentiation, ES cells were transfected with p53 
or p21 siRNA for 2 d, followed by 12 dyne/cm
2 laminar fl  ow 
treatment for 24 h. Western blot analysis showed that p53 siRNA 
treatment decreased shear-induced p53 and p21 protein produc-
tion, and that shear-induced eNOS and Flt-1 protein levels were 
also decreased (Fig. 3 A). Meanwhile, p21 siRNA treatment 
  decreased p21 proteins as expected, and shear-induced eNOS, 
Flk-1, and Flt-1 induction was ablated (Fig. 3 B). Shear-induced 
CD144 reporter gene expression was signifi  cantly decreased by 
treatment with either p53 or p21 siRNAs, although both siRNA 
treatments did not completely block CD144 reporter expression 
(unpublished data).
p53-mediated p21 activation was through 
deacetylation by HDAC3
As shown in Fig. 4 A, p53 acetylation at Lys317 and Lys370 
sites was decreased, although p53 proteins were increased  under 
shear, suggesting that laminar fl  ow increases p53 deacetylation. 
To explore the role of HDACs in p53 deacetylation by shear, 
HDAC activity was detected in cell lysates from static and 
Figure 2.  Up-regulation of p53 and p21 cor-
related with shear-induced EC differentiation. 
(A) Shear up-regulated p53 and p21 proteins 
in ES cells. SS, shear stress. (B) Double immuno-
ﬂ  uorescence staining showing the colocaliza-
tion of p53 or p21 with CD106 in sheared-ES 
cells. (C) Overexpression of p53 and p21 in-
creased EC marker reporter gene expression 
in ES cells. (D) FACS analysis showing the ef-
fect of overexpression of p53 by   Ad-p53 (mul-
tiplicity of infection [MOI] = 50) on CD31, 
CD133, CD106, and CD144 expression. 
Ad-LacZ virus was included as a control. 
*, P < 0.05. (E) Representative images show-
ing X-gal, anti-p53, p21, and CD144 staining 
of serial sections of inoculates from Ad-p53–
  infected ES cells. The data are representatives 
or means ± the SD from three independent 
  experiments. Bars, 50 μm.JCB • VOLUME 174 • NUMBER 7 • 2006  1062
sheared samples. Refreshment of growth medium slightly 
  increased HDAC activity in static cells, which may be caused 
by growth factor stimulation present in the serum, whereas 
  application of laminar fl  ow on ES cells resulted in a signifi  cant 
elevation in HDAC activity, with a peak at  6 h (Fig. 4 B). 
Western blot analysis revealed that HDAC1 and HDAC3 pro-
teins were up-regulated by shear in a pattern similar to HDAC 
activity (Fig. 4 C), whereas other types of HDACs were unde-
tectable or slightly decreased by shear (not depicted). As further 
studies revealed that HDAC1 was less relevant in EC differenti-
ation, we focused our studies on HDAC3. Cotransfection assay 
showed that overexpression of HDAC3 could enhance p53-
  mediated p21-Luc reporter gene expression (Fig. 4 D).
To further confi  rm the role of HDAC3 in p53 deacety-
lation and p21 activation and its potential role in shear-
  induced EC differentiation, the HDAC inhibitor TSA was 
included in shear experiments. TSA completely abolished 
shear-induced HDAC activation (Fig. 5 A). As expected, 
shear-induced HDAC3 activation and p53 deacetylation were 
ablated, as revealed by an increase in p53 acetylation. TSA 
treatment led to an increase in p21 and eNOS proteins in 
static cells; shear stress could not increase these proteins any 
more in the presence of TSA, indicating that shear stress does 
not cooperate with TSA in the enhancement of these gene 
  expressions (Fig. 5 B). When ES cells were transfected with 
HDAC3 siRNA, shear-induced p53 deacetylation, p21 activa-
tion, and Flt-1 expression were signifi  cantly reduced, as dem-
onstrated by Western blot analysis (Fig. 5 C). Luciferase 
reporter assay revealed that HDAC3 siRNA treatment slightly 
inhibited CD144 reporter gene expression under static condi-
tions, but signifi  cantly reduced shear-induced CD144 reporter 
gene expression (unpublished data). Overexpression of p21 
partially rescued HDAC3 siRNA-mediated suppression of 
Flt-1 reporter gene expression (Fig. 5 D). These results indi-
cate that HDAC3-mediated p53 deacetylation and p21 activa-
tion are essential for shear-induced EC differentiation from 
ES cells.
Figure 3.  Knockdown of p53 and p21 ablated shear-induced EC 
  differentiation. (A) Western blot analysis showing the effect of p53-siRNA 
on shear-induced p53, p21, eNOS, and Flt-1 proteins. Untransfected cells 
(ctl) and control siRNA (ctlsi) were included as controls. (B) Western blot 
analysis showing the effect of p21 siRNA on shear-induced p21 expres-
sion, eNOS, Flk-1, and Flt-1 protein production. The data are representa-
tive of three independent experiments.
Figure 4.  HDAC3 contributed to shear-induced p53 
deacetylation and p21 activation. (A) Western blot to de-
tect p53 acetylation status at Lys317 and Lys370 and p21 
activation in duplicate slides from cells sheared for 24 h. 
(B) HDAC activity detected in static and shear samples 
harvested at the times indicated. (C) HDAC1 and HDAC3 
proteins were up-regulated by shear treatment. (D) Over-
expression of HDAC3 enhanced p53-mediated p21 re-
porter gene expression. The data are means ± the SD of 
three independent experiments.HDAC3 IN ENDOTHELIAL CELL DIFFERENTIATION • ZENG ET AL. 1063
The involvement of Flk-1–PI3K–Akt 
signal pathways
Western blot analysis demonstrated that both RNA and the 
protein synthesis inhibitors actinomycin D and cycloheximide 
decreased HDAC3 protein levels in static cells. When laminar 
fl  ow was applied, HDAC3 increased by a similar fold ( 1.5-
fold) in the absence or presence of the inhibitors (Fig. 6 A), 
implicating that shear stress up-regulates HDAC3 by post-
translation stabilization. To clarify the upstream signal path-
ways, we studied VEGF and related signal transducers. In the 
presence of VEGF antagonist SU1498, shear stress could not 
increase HDAC3 proteins further, and the HDAC activity was 
abolished (Fig. 6, B and C). Consequently, shear-induced p53 
deacetylation, p21 activation, and eNOS expression were 
  ablated (Fig. 6 B). These results indicate that VEGF receptor 
Flk-1 is crucial for shear-induced HDAC3 stabilization and 
EC differentiation. It has been reported that shear stress acti-
vated Flk-1 in a ligand-independent manner (Jin et al., 2003; 
Yamamoto et al., 2005). To explore whether ligand-dependent 
activation of Flk-1 could also contribute to HDAC3 stabiliza-
tion, the effect of VEGF-165 on HDAC activity and HDAC3 
proteins were detected in ES cells. VEGF-165 treatment tran-
siently increased HDAC3 proteins (Fig. 6 D) with concomi-
tant increase of HDAC activity (not depicted). Furthermore, 
both laminar fl  ow and VEGF-165 treatment resulted in Akt 
phosphorylation, but different effects were observed on ERK 
phosphorylation (Fig. 6, E and F). Flk-1 inhibitor SU1498 
abolished both shear- and VEGF-induced HDAC3 stabiliza-
tion and Akt phosphorylation. ERK Kinase (MAKK) inhibitor 
PD98059 inhibited VEGF-induced ERK phosphorylation, but 
no effect on shear and VEGF-induced HDAC3 stabilization 
and Akt phosphorylation, whereas PI3K inhibitor LY294002 
inhibited both shear- and VEGF-induced HDAC3 stabiliza-
tion and Akt phosphorylation.
Similarly, HDAC3 was also demonstrated to be crucial for 
VEGF-induced EC differentiation, as HDAC3 siRNA ablated 
VEGF-induced EC marker gene reporter (eNOS-Luc, Flt-1-
Luc, and vWF-Luc) expression in ES cells (Fig. 7 A), and high 
levels of HDAC3, p53, and p21 were detected in VEGF-induced 
blood vessels (Fig. 7 B). 
HDAC3 and p21 was highly expressed 
in embryonic blood vessel
As described above, the HDAC3–p53–p21 pathway was essen-
tial for shear- and VEGF-induced ES cell differentiation toward 
endothelial lineage in vitro, and might function in the in vivo 
blood vessel formation derived from these cells. To explore 
whether such a pathway was also involved in angiogenesis 
  during embryonic development, their expression was checked 
in blood vessels of 13.5 d Tie2-LacZ–transgenic mice embryos. 
As shown in Fig. 7 C, blood vessels were positively stained 
for β-gal and CD31 in endothelium, whereas HDAC3 and p21 
labeled the whole vessel wall. These results suggest that 
HDAC3 and p21 may be involved in vasculogenesis during 
 embryo  development.
ES cell–derived Sca1
+ progenitor cells 
repair injured vessels
To explore whether the in vitro–produced EPCs could incorpo-
rate into the injured vessel and increase the repair in vivo, a 
femoral artery injury model was conducted in ApoE
−/− mice. 
Considering that in vitro–differentiated ECs directly from ES 
cells take up only a small portion of the cell population, and that 
other types of cells might interfere with the experiment,  Sca1
+ 
Figure 5.  Inhibition of HDAC3 ablated shear-induced 
p53 deacetylation, p21 activation, and EC differentiation. 
(A) TSA abolished shear-induced HDAC activation. 
(B) TSA blocked shear-induced HDAC3 activation, p53 
deacetylation, p21 activation, and EC differentiation. 
(C) Western blot data showing the effect of HDAC3 siRNA 
on shear-induced p53, acetyl-p53Lys370, p21, HDAC3, 
and Flt-1 proteins. Untransfected cells (ctl) and control 
siRNA (ctlsi) were included as controls. (D) Overexpres-
sion of p21 partially rescued HDAC3 siRNA–mediated 
suppression of Flt-1 reporter gene expression. The data 
are representatives or means ± the SD from three inde-
pendent experiments.JCB • VOLUME 174 • NUMBER 7 • 2006  1064
progenitor cells were alternatively used. As shown in Fig. 8 A, 
β-gal–labeled exogenous VEGF-treated Sca1
+ cells incorpo-
rated into the injured vessel wall when checked on day 3, which 
also showed CD31-positive staining. The injured vessel was 
completely occluded by neointimal lesions 2 wk postoperatively 
(Fig. 8 B, b). However, local transfer of VEGF-treated Sca1
+ 
cells signifi  cantly reduced neointima lesions (Fig. 8 B, c and d). 
Statistically, the progenitor cell–treated group had neointimal 
lesions decreased by  30–40% (Fig. 8 B, e). To further explore 
whether shear stress–induced EPCs had similar function, Sca1
+ 
cells were selected from 24-h sheared ES cells. FACS analysis 
showed that Sca1
+ cells took up  15% of the population in 
sheared ES cells before sorting, and >95% after sorting. After 
expansion, the shear stress–induced Sca1
+ cells were used in 
similar femoral artery injury repair experiments. As expected, 
shear stress–induced Sca1
+ cells could also incorporate into the 
injured vessel (Fig. 8 C, c) and reduced the neointima formation 
(Fig. 8 C, b, d, and e) to a lesser extent, as compared with 
VEGF-treated Sca1
+ cells (Fig. 8, B [e] vs. 8 C [e]). These re-
sults demonstrate that the in vitro–differentiated EPCs and/or 
ECs can incorporate into injured artery and reduce neointimal 
lesions by increased repairing.
Discussion
Under specifi  c stimulation, e.g., growth factors (Schaper and 
Scholz, 2003), extracellular matrix (Kleinman et al., 2003), 
mechanical forces (Ingber, 2002; Schaper and Scholz, 2003), 
and coculture with other cell types (Shen et al., 2004; Wurmser 
et al., 2004), progenitor cells undergo specifi  c lineage differ-
entiation. In this study, we demonstrate that laminar fl  ow en-
hances the differentiation of stem cells into functional ECs. 
We show for the fi  rst time that HDAC3 deacetylates p53, lead-
ing to p21 activation and resulting in differentiation of stem/
progenitor cells into mature ECs. We also provide evidence 
that shear activates HDAC3 by posttranslation stabilization 
through Flk-1–PI3K–Akt signal pathways, and that HDAC3 
and p21 may be involved in blood vessel formation in vivo. 
Our fi  ndings of mechanistic aspects for shear-induced stem 
Figure 6.  Shear- and VEGF-stabilized HDAC3 through Flk-1–PI3K–Akt 
signal pathways. (A) RNA and protein synthesis inhibitors did not affect 
shear-increased HDAC3 protein production. (B) Flk-1 inhibitor ablated 
shear-induced HDAC3 stabilization, p53 deacetylation, p21 activation, 
and EC differentiation. (C) Flk-1 inhibitor abolished shear-induced HDAC 
activation. (D) VEGF transiently up-regulated HDAC3 protein induction. 
(E) Western blot data showed that shear-induced HDAC3 stabilization was 
related to Flk-1–mediated Akt phosphorylation. (F) Western blot analysis 
revealed that VEGF-induced HDAC3 stabilization was related to Flk-1–
  mediated Akt phosphorylation. AD, actinomycin D; CH, cycloheximide; LY, 
LY294002; PD, PD98059; SS, shear stress; SU, SU1498. The data are 
representatives or means ± the SD from three independent experiments.
Figure 7.  HDAC3 was involved in VEGF-induced EC differentiation 
and blood vessel formation in vivo. (A) HDAC3 siRNA ablated VEGF-
  induced EC marker expression in ES cells. The data are means ± the SD of 
three independent experiments. (B) A representative of immunohistological 
staining for CD144, HDAC3, p53, and p21 in blood vessels formed by 
VEGF-treated Sca1
+ cells. (C) A representative of the X-gal staining and 
  immunohistological staining for CD31, HDAC3, and p21 in blood vessels 
in D13.5 embryonic sections from Tie2-LacZ/ApoE
−/− mice. Bars, 200 μm.HDAC3 IN ENDOTHELIAL CELL DIFFERENTIATION • ZENG ET AL. 1065
cell differentiation toward ECs could signifi  cantly enhance 
our knowledge on stem cells involved in vasculogenesis, 
  angiogenesis, and vascular repair.
Cultured on collagen IV–coated plates in the absence 
of LIF for 3–4 d, ES cells could spontaneously differentiate 
into EPCs, some even into mature ECs, as identifi  ed by the up-
regulation of EPC markers, e.g., Flk-1, CD31, CD133, eNOS, 
and the EC marker CD144. We propose that shear stress signifi  -
cantly enhances both processes, i.e., vascular progenitor differ-
entiation into EPCs, and EPCs into ECs. Shear-produced EPCs 
could be derived from the differentiation of bipotential vascular 
progenitor cells. Supporting this notion is the fact that vascular 
progenitor cells can differentiate into both vascular smooth 
muscle cells and ECs in response to PDGF and VEGF treat-
ment, respectively (Yamashita et al., 2000). Previous studies 
showed that shear stress induced EC differentiation, while sup-
pressing smooth muscle differentiation (Wang et al., 2005). In 
our experiments, we also observed that smooth muscle differen-
tiation was down-regulated by shear stress (unpublished data). 
It seems that shear-induced EC differentiation is at the cost of 
reduced smooth muscle differentiation. If this is also true for 
adult vessels in vivo, a better explanation could be offered as 
to why high-shear areas in the arterial wall have an integrative 
endothelium that is resistant to atherosclerosis. Thus, vascular 
progenitor differentiation toward ECs could be infl  uenced by 
shear stress in vivo.
VEGF receptor 2 (Flk-1) is a major progenitor cell marker 
for hematopoietic and endothelial lineage, expressed from he-
mangioblast to mature ECs (Schatteman and Awad, 2004). Flk-1 
mediates not only VEGF-induced EC differentiation but also 
VEGF-induced mature endothelial function, such as prolifera-
tion, migration, permeability, and cell survival (Claesson-Welsh, 
2003; Ferrara et al., 2003; Zachary, 2003; Coultas et al., 2005). 
It was reported that shear stress could activate Flk-1 in a ligand-
independent manner (Jin et al., 2003; Yamamoto et al., 2005).
We demonstrated that shear stress–induced EC differentiation 
was mediated through Flk-1, as the Flk-1–specifi  c inhibitor 
SU1498 abolishes shear-induced eNOS expression. Activation 
of Flk-1 can trigger several downstream signal pathways, 
among which the PI3K–Akt pathway is defi  ned to cell survival, 
whereas the PLC–ERK pathway is defi  ned to proliferation (Fujio 
and Walsh, 1999; Takahashi et al., 2001; Cross et al., 2003). 
Figure 8.  Sca1
+ cells incorporated into injured artery 
and reduced lesion formation in ApoE
−/− mice. (A) X-gal 
and double immunoﬂ  uorescence staining showed the in-
corporation of VEGF-treated Sca1
+ cells into the injured 
femoral artery. (B) VEGF-treated Sca1
+ cell reduced the 
lesion formation caused by artery injury. a, uninjured 
  artery; b, injured artery without cell treatment; c, injured 
artery with cell treatment; d, higher magniﬁ  cation of im-
age c; e, statistical analysis of the ratio of neointima to the 
media. (C) Shear stress–induced Sca1
+ cell reduced the 
lesion formation caused by artery injury. a, uninjured ar-
tery; b, injured artery without cell treatment; c, X-gal stain-
ing showed the incorporated Sca1
+ cell; d, injured artery 
with Sca1
+ cell treatment; e, statistical analysis of the ratio 
of neointima to the media. Data are means ± the SD from 
six animals per group. Bars: (A–C) 100 μm; (c) 50 μm.JCB • VOLUME 174 • NUMBER 7 • 2006  1066
In ES-derived progenitor cells, shear stress activated Akt phos-
phorylation but suppressed ERK phosphorylation, whereas 
VEGF activated both Akt and ERK phosphorylation. Moreover, 
we demonstrated for the fi  rst time that the PI3K–Akt pathway 
led to HDAC3 activation. Akt phosphorylation status correlated 
with HDAC3 protein levels, and its inhibition by SU1498 and 
LY294002 abolished shear-induced HDAC3 protein increase. 
Further investigation of how Akt phosphorylation modulates 
HDAC3 is necessary.
Previous studies reported that inhibition of HDAC activity 
by TSA blocked tumor angiogenesis, especially hypoxia-
  induced angiogenesis (Sawa et al., 2002; Liu et al., 2003). It is 
well known that hypoxia induces tumor angiogenesis and cell 
survival through the up-regulation of VEGF expression in 
tumor cells (Harris, 2002; Byrne et al., 2005). These studies 
  provide indirect evidence for the potential role of HDACs in EC 
differentiation. Although Rossig et al. (2005) reported that 
shear-activated HDAC1 and HDAC3 were involved in shear-
  induced adult EPC differentiation through up-regulation of 
HoxA9, we demonstrated that HDAC3 activation led to p53 
deacetylation and, in turn, to p21 activation. In this study, HDAC3 
was found to be activated by shear stress and VEGF, whereas 
  inhibition of HDAC activity by TSA or siRNA-mediated knock-
down of HDAC3 abolished shear- and VEGF-  induced EC 
marker gene expression. Collectively, these results suggest 
an essential role of HDAC3 in shear- and VEGF-induced stem 
cell differentiation in vitro, and a potential role in blood vessel 
formation in vivo.
Evidence indicates that lack of p21 expression increases 
EPC sensitivity to apoptosis, with retarded EC maturation 
(Lai et al., 2003; Bruhl et al., 2004). In this study, we demon-
strated that shear stress activated p21 through p53 deacetylation 
mediated by HDAC3, and that p21 activation was essential for 
shear-induced EC differentiation. p53 knockdown ablated shear-
induced p21 activation, indicating that p21 activation by shear is 
p53-  dependent. Both inhibition of HDAC activity by TSA and 
HDAC3 siRNA decreased shear-induced p53 deacetylation and 
p21 activation, implicating that p21 activation is also HDAC3 
dependent. Other evidence came from the observations that 
overexpression of HDAC3 could enhance p53-mediated p21 ex-
pression, and high levels of HDAC3 and p21 were detected in 
blood vessels formed from in vitro–differentiated ECs and dur-
ing embryogenesis. Other studies showed that p53 acetylation 
was linked to p21 activation (Di Stefano et al., 2005; Zhao et al., 
2006). The discrepancy may be caused by different cell types. 
In response to different stimuli, native p53 and acetylated p53 
recruit different coactivators to form a complex binding to p21 
promoter. We show that HDAC3, p53, and p21 are directly 
linked to EC differentiation in vitro. These fi  ndings suggest that 
p21 is downstream of HDAC3 and plays a central role in shear-
induced EC differentiation.
In this study, we also observed that in vitro–differentiated 
EPCs/ECs could form blood vessels in vivo, and appear to play 
a crucial role in endothelial restoration and vascular repair. 
  Treatment with these vascular progenitors led to a signifi  cant 
  reduction of neointimal lesions in a mouse model of femoral 
artery injury, through replacement of the denuded endothelium. 
Newly isolated Sca1
+ progenitor cells were less effective than 
VEGF-treated ones. The discrepancy was derived from the obser-
vation that vascular progenitor cells were able to differentiate to-
ward both smooth muscle cell and EC, whereas VEGF induced 
specifi  c differentiation toward endothelial lineage (Yamashita 
et al., 2000). Indeed, VEGF-treated cells showed much more EC 
marker expression. The functionally intact endothelial monolayer 
suppresses the recruitment of infl  ammatory cells and, thus, mod-
ulates the process of vascular remodeling and down-regulates in-
tima hyperplasia. These observations provide further support to 
the concept that differentiation of stem cells toward ECs is bene-
fi  cial to the blood vessel.
In summary, this study demonstrates that shear stress ac-
tivates Flk-1 and its downstream PI3K–Akt cascade, resulting 
in the activation of HDAC3, which in turn deacetylates p53 
and activates p21. p21 activation results in stem cell differen-
tiation into ECs and an increase in their survival. HDAC3 may 
also be involved in epigenetic modifi  cation of the chromatin 
to regulate gene transcription, which is essential for modula-
tion of EC marker gene expression, together, leading to stem 
cell differentiation. Thus, HDAC3 is essential for shear- and 
VEGF-mediated stem cell differentiation, which can be a new 
target for therapeutic use.
Materials and methods
Materials
Antibodies against CD31 (rat), Flk-1, and Flt-1 were purchased from 
  Abcam; antibodies against CD106 (rat) and CD144 (rat) were obtained 
from BD Biosciences; antibody against CD133 (rat) was purchased from 
eBioscience; antibodies against β-gal, CD31 (goat), CD144 (mouse), 
HDAC1, p21, p53, p-AktThr308, Akt1/2 (goat), pERK42/44, and ERK2 
were obtained from Santa Cruz Biotechnology, Inc.; antibodies against 
eNOS, HDAC3, and α-tubulin (mouse) were purchased from Sigma-
  Aldrich; and antibodies against acetylated p53Lys320 and p53Lys373 were 
obtained from Millipore. All antibodies were raised in rabbit, except those 
indicated. All secondary antibodies were purchased from  DakoCytomation. 
The inhibitors actinomycin D (1 μg/ml), cycloheximide (30 μg/ml), 
LY294002 (5 μM), PD98059 (5 μM), SU1498 (1 μM), and TSA (50 nM) 
were purchased from Sigma-Aldrich, dissolved in DMSO, and used at the 
indicated concentrations. The cells were pretreated with a speciﬁ  c inhibitor 
for 1 h before further treatment in the presence of the inhibitor. Other 
chemicals were also purchased from Sigma-Aldrich.
Cells and cell culture
Mouse ES cells (ES-D3 cell line, CRL-1934; American Type Culture Collec-
tion [ATCC]) were maintained as previously described (Vittet et al., 1996). 
In brief, the ES cells were cultured in gelatin-coated ﬂ  asks in DME (ATCC) 
supplemented with 10% FBS (ATCC), 10 ng/ml LIF (CHEMICON Interna-
tional, Inc.), 0.1 mM 2-mercaptoethanol, 100 U/ml penicillin, and 
100 μg/ml streptomycin in a humidiﬁ  ed incubator supplemented with 5% 
CO2, and they were split at a 1:6 ratio every other day. Sca1
+ cells were 
isolated as previously described (Hu et al., 2004), and maintained in the 
same condition as ES cells. Both ES and Sca1
+ cells were used for <20 
passages in this study. For differentiation, ES or Sca1
+ cells were prediffer-
entiated by culture on mouse collagen IV (5 μg/ml)–coated glass slides or 
ﬂ  asks or plates in differentiation medium (DM; α-MEM medium [Invitrogen] 
supplemented with 10% FBS [Invitrogen], 0.05 mM 2-mecaptoethanol, 
100 U/ml penicillin, and 100 μg/ml streptomycin) for 3 or 4 d before 
  further treatment. The medium was refreshed every other day.
Shear and VEGF treatment
Shear experiments were conducted as previously described (Zeng et al.,   
2003). In brief, the predifferentiated cells were exposed to a laminar ﬂ  ow 
generated by the pressure difference between the upper and lower reser-
voirs, with the efﬂ  uent DM medium circulated back to the upper reservoir 
through a peristaltic pump. The shear stress, which is determined by the HDAC3 IN ENDOTHELIAL CELL DIFFERENTIATION • ZENG ET AL. 1067
ﬂ  ow rate and the channel dimensions, was 12 dyne/cm
2, which is compa-
rable with the physiological range in human major arteries. The entire ﬂ  ow 
system was placed in an incubator at 37°C and supplemented with 5% 
CO2 to maintain pH. Static controls were cells cultured on slides not 
  exposed to ﬂ   ow. To prevent contamination, 5 μg/ml gentamycin and 
0.1 μg/ml doxycycline were included in shear medium.
For VEGF-induced HDAC activation assay, the predifferentiated ES 
cells were pretreated with serum-free α-MEM supplemented with 0.05 mM 
2-mercaptoethanol and antibiotics for 2 h, followed by treatment with 
10 ng/ml mouse VEGF-165 (Bender Medsystems) for the time indicated in 
Fig. 6 D. For HDAC3 siRNA assay, the predifferentiated ES cells were 
transfected with HDAC3 siRNA or control siRNA for 2 d, followed by 
10 ng/ml VEGF-165 treatment in serum-free α-MEM supplemented with 
0.05 mM 2-mercaptoethanol, 1% BSA, 10 ng/ml insulin, and antibiotics 
for 24 h. For VEGF-induced differentiation, Sca1
+ cells were cultured in 
DM medium in the presence of 10 ng/ml VEGF-165 for 1 wk, followed by 
either an in vivo angiogenesis assay or a femoral injury repair experiment.
Cell proliferation and ﬂ  ow cytometry analysis
A portion of the 24-h sheared or static cells was seeded in 12-well plates 
in the presence of MTT reagents (Promega) for 1 h, and the cell prolifera-
tion was detected according to the protocol provided. The procedure used 
for ﬂ  ow cytometry was similar to that previously described (Mayr et al., 
2000). Rat anti-CD31, CD106, CD133, and CD144 antibodies were 
used for EC markers.
In vitro tube formation assay
The procedure used was similar to that described previously (Kaufman 
et al., 2004). Cell suspension containing 4 × 10
4 static or sheared ES 
cells was placed on top of the 50 μl/well Matrigel (10 mg/ml; Becton 
Dickinson) in 8-well chamber slides (Nunc). Rearrangement of cells and 
the formation of capillary-like structures were observed at 18–24 h. 
Cells were ﬁ  xed with 4% paraformaldehyde in PBS at 4°C overnight, 
and then HE staining was performed. Images were assessed with Axio-
plan 2 imaging microscope with Plan-NEOFLUAR 10×, NA 0.3, objec-
tive lenses, AxioCam camera, and Axiovision software (all Carl Zeiss 
MicroImaging, Inc.) at room temperature, and were processed with 
  Photoshop software  (Adobe).
In vivo angiogenesis assay, embryo section preparation, 
and femoral artery injury
All cells were labeled with the Ad-LacZ virus (MOI = 20) before in vivo 
angiogenesis assay to distinguish the in vitro–differentiated cells from 
the host cells. 10
6 cells were pelleted and mixed with 50 μl Matrigel, 
and then injected subcutaneously into the back or ﬂ   ank of C57BL/6 
mice. Six injections were conducted for each group. The mice were 
killed on days 7 and 14, and the plaques were harvested and frozen 
immediately in liquid nitrogen, followed by embedding with OCT and 
sectioning. 13.5-d embryos were collected from Tie2-LacZ/ApoE
−/− 
mice (Hu et al., 2004) and cryosectioned.
For artery injury model, both the left and right femoral arteries of 
ApoE
−/− mice were injured by wire. Ad-LacZ virus–labeled Sca1
+ cells 
(10
6) in 30 μl PBS were injected into one artery, 30 μl PBS was injected 
into the other side as a control, and both were incubated for 30 min, 
  followed by restoring the blood ﬂ  ow. Arteries were harvested at day 3 for 
cryosections or day 14 for formalin-ﬁ   xed sections. The sections were 
stained with HE or X-gal (Hu et al., 2003), or immunohistologically stained 
with speciﬁ  c antibodies, and observed under the microscope. Images were 
assessed and processed as described above except 20×, NA 0.5, and 
40×, NA 0.75, objective lenses were used instead. All animal experi-
ments were performed according to protocols approved by the Institutional 
Committee for Use and Care of Laboratory Animals.
Immunoblotting, immunoﬂ  uorescence staining, and HDAC activity assay
Cells were harvested and lysed by sonication. 50 μg of whole cell lysate 
was subjected to standard immunoblotting procedure and probed with 
primary antibodies as indicated. The bound primary antibody was 
  detected by use of HRP-conjugated secondary antibody and the ECL de-
tection system (GE Healthcare). The procedure used for immunoﬂ  uores-
cence staining was similar to that described previously (Xu et al., 2003). 
Rabbit anti–β-gal, p53, and p21, and rat anti-CD31, CD106, and 
CD144 antibodies were used. Swine anti–rabbit IgG-FITC and swine 
anti–rat IgG–TRITC antibodies were used to label the bound primary 
  antibodies, which were   illuminated by blue and green light, respectively. 
Images were assessed and processed as described in the previous para-
graph, except that 40×, NA 0.75, objective lenses were used instead. 
HDAC activity was determined by using the Colorimetric HDAC Activity 
Assay kit (BioVision) with the protocol provided. The cells were lysed by 
sonication, and 50 μg of whole cell lysate was used to detect HDAC 
  activity; relative HDAC activity was deﬁ  ned as A405 nm/μg protein, 
with that of control set as 1.0.
Plasmids and transient transfection and adenoviral infection
The expression vectors for HDAC3, p21, and p53, and the reporter 
  systems for CD144, eNOS, Flk-1, Flt-1, and vWF were cloned with vec-
tors and primers in Table I. For transient transfection, ES cells were cul-
tured in a collagen IV–coated 12-well plate for 3 d, and then transfected 
with   reporter gene (0.33 μg/well) together with expression plasmids 
(0.33 μg/well) and/or siRNA (0.033 nmol/well) using Fugene 6 reagent 
(Invitrogen) according to the protocol provided. pShuttle2-LacZ plasmid 
(0.15 μg/well) was included in all transfection assays as internal control, 
and pShuttle2 vector and control siRNA were used as a mock control. 
Luciferase activity assay was performed at 36 or 72 h (siRNA) after trans-
fection. Luciferase and β-galactosidase activities were detected with stan-
dard protocol. Relative luciferase unit was deﬁ  ned as the ration of luciferase 
activity to β-galactosidase activity, with that of controls set as 1.0.
Table I. Vectors and primer sequences for plasmid construction
Gene name Vector name Primer sequence
HDAC3 pShuttle2-Flag
a 5′-atg acc ggt acc gtg gcg tat ttc tac gac-3′
5′-cac agc aag ctt gct gct cta aat ctc cac-3′
p21 pShuttle2-Flag 5′-gag aca ggt acc tcc aat cct ggt gat gtc-3′
5′-aga gag gaa gct tga ccc aca gca gaa gag-3′
p53 pShuttle2 5′-tgg atg gct agc atg gag gag tca cag tcg-3′
5′-tgg tga ctt aag cgg gat gca gag gca gtc-3′
CD144 promoter pGL3-Luc basic 5′-gac aag gag ctc tgg aag agc aac tga tgc-3′
5′-gtt cag gct cga gct ttg tgg aga gca cag-3′
ENOS promoter pGL3-Luc basic 5′-acc gac ctc gag aag aac cta gca gtg g-3′
5′-agt tgc aag ctt cag ctg acc tca act ctg-3′
Flk-1 promoter pGL3-Luc basic 5′-gac tac ctc gag cca gga agt tca caa cc-3′
5′-gtc ctg aag ctt ctc agg gca gaa aga gag-3′
Flt-1 promoter pGL3-Luc basic 5′-gac gtt ctg agc tct tac aag ttg cag gag-3′
5′-cac tgc gag ctc tca agg acc tcg ctg-3′
VWF promoter pGL3-Luc basic 5′-tgc cag ctc gag aac ttg taa gac caa ctc-3′
5′-tgc cag aag ctt ctc tgc ctg caa tag ctc-3′
apShuttle2-Flag was a modiﬁ   ed expression vector, which was constructed by replacing the NheI–MCS–Aﬂ   II fragment with NheI–Flag–MCS–Aﬂ  II  fragment;  the 
latter fragment was ampliﬁ  ed from pCMV5-Flag vector with primer set of 5′-tgc ctg gct agc atg gac tac aag gac gac gat-3′ and 5′-tca ctt act taa gct gga tcc tct 
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Predifferentiated ES cells were infected with Ad-p53 viruses at a 
MOI of 50 for 12 h, followed by in vivo angiogenesis assay, or for 36 h, 
followed by FACS analysis. Ad-tTA and Ad-LacZ viruses were used as 
  controls, respectively.
siRNA knockdown
The siRNAs for p53(sc-29436) and p21(sc-29428) were purchased from 
Santa Cruz Biotechnology, Inc. The control siRNA and the siRNA for HDAC3 
(5′-ccucaucgccuggcauugatt-3′ and 5′-ucaaugccaggcgaugaggtt-3′) were pur-
chased or synthesized from Ambion. For the siRNA knockdown experiments, 
ES cells were cultured on collagen IV–coated slides (38 × 76 mm) for 3 d, 
and the medium was refreshed at 24 h and 1 h before transfection. 10 μl of 
10 mM siRNA per slide was introduced into the cells with siIMPORTER trans-
fection reagents (Millipore), according to the manufacture’s protocol. The un-
treated and nonrelated siRNA-transfected cells were included as controls. For 
speciﬁ  c target genes, siRNA transfection was performed in duplicate. The 
transfected cells were cultured for an additional 48 h and subjected to 
12 dyne/cm
2 laminar ﬂ  ow for 24 h, followed by Western blot analysis.
Statistical analysis
Data expressed as the mean ± the SEM were analyzed with a two-tailed 
t test, for two groups, or pair-wise comparisons. A value of P < 0.05 was 
considered to be signiﬁ  cant.
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